SELECT MEDICAL HOLDINGS CORP
SEMNYSEHealthcare · Services-Hospitals · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $5.45B | $1.32B | $1.21B | $4.61B | $6.20B | $5.53B |
| Operating income | $336.2M | $268.3M | $267.2M | $144.8M | $713.8M | $567.7M |
| Net income | $146.2M | $96.9M | $70.8M | $159.0M | $402.2M | $259.0M |
| Total assets | $5.85B | $5.61B | $7.69B | $7.67B | $7.36B | $7.66B |
| Total liabilities | $3.82B | $3.61B | $6.12B | $6.27B | $6.00B | $6.00B |
| Equity | $1.71B | $1.68B | $1.29B | $1.12B | $1.11B | $1.06B |
| EPS (diluted) | $1.16 | $1.66 | $1.91 | $1.23 | $2.98 | $1.93 |
| Shares out. | 129.0M | 128.4M | 127.2M | 133.9M | 134.8M | 134.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 6.2%
- Net margin
- 2.7%
- Return on equity
- 8.6%
- Return on assets
- 2.5%
- Return on capital (ROCE)
- 6.9%
- Liabilities / assets
- 65.2%
- Debt / equity
- 2.24×
- Book value / share
- $13.23
- Revenue growth (YoY)
- 312.7%
- Net income growth (YoY)
- 50.9%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 1.37grey zone
- Accruals / assets
- −3.4%clean
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 warning● 4 good- Altman Z″ in the grey zone
- Operating margin is positive
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Glazer Capital, LlcPassive (13G)May 14, 2026
- Vanguard Portfolio Management LlcPassive (13G)Apr 29, 2026
- Price T Rowe Associates Inc /Md/Passive (13G)Apr 8, 2026
- Vanguard Group IncPassive (13G)Mar 27, 2026
- Ortenzio Robert AActivist (13D)Mar 4, 2026
- Blackrock, Inc.Passive (13G)Apr 29, 2025
- Ortenzio Rocco APassive (13G)Jan 30, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Breighner Robert G. JrOfficer — SENIOR VICE PRESIDENT | May 4, 2026 | Tax withholding | 1,330 | $16.44 |
| Chernow David SOfficer — Vice Chairman | Apr 30, 2026 | Tax withholding | 22,586 | $16.41 |
| Frist William H.Director | Apr 28, 2026 | Grant | 1,094 | $16.45 |
| Frist William H.Director | Feb 11, 2026 | Grant | 1,109 | $16.23 |
| Duggan John F.Officer — Executive Vice President | Nov 1, 2025 | Tax withholding | 4,865 | $13.83 |
| Malatesta Michael FOfficer — CHIEF FINANCIAL OFFICER | Nov 1, 2025 | Tax withholding | 7,357 | $13.83 |
| Duggan John F.Officer — Executive Vice President | Oct 28, 2025 | Grant | 50,000 | $0.00 |
| Frist William H.Director | Oct 28, 2025 | Grant | 1,266 | $14.22 |
| Weigl ChristopherOfficer — CHIEF ACCOUNTING OFFICER | Oct 28, 2025 | Grant | 20,000 | $0.00 |
| Saich John A.Officer — EXECUTIVE VICE PRESIDENT | Aug 1, 2025 | Tax withholding | 21,745 | $12.57 |
| Mullin Thomas POfficer — CO-PRESIDENT | Aug 1, 2025 | Tax withholding | 22,045 | $12.57 |
| Tarvin Michael EOfficer — EXECUTIVE VICE PRESIDENT | Aug 1, 2025 | Tax withholding | 19,640 | $12.57 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 2.5M | 1.8 | +10.4% |
| Apr 30, 2026 | 2.2M | 1.3 | -16.3% |
| Apr 15, 2026 | 2.7M | 1.8 | -2.5% |
| Mar 31, 2026 | 2.7M | 1.1 | +19.4% |
| Mar 13, 2026 | 2.3M | 1.0 | -24.4% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operations · Director / officer change · Other material eventApr 30, 2026
- Shareholder voteApr 24, 2026
- Entered a material agreement · Regulation FD disclosureMar 3, 2026
- Results of operations · Other material eventFeb 19, 2026
- Director / officer changeDec 19, 2025
- Regulation FD disclosureNov 25, 2025
- Results of operations · Other material eventOct 30, 2025
- Director / officer change · Regulation FD disclosureSep 2, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- SC 13E3/AMay 20, 2026
- DEFM14AMay 20, 2026
- SC 13E3/AMay 15, 2026
- PRER14AMay 15, 2026
- SCHEDULE 13GMay 14, 2026
- 4May 5, 2026
- 4May 1, 2026
- 8-KFORM 8-KApr 30, 2026
- 10-QApr 30, 2026
- 4Apr 29, 2026
- SCHEDULE 13GApr 29, 2026
- 8-KFORM 8-KApr 24, 2026
- SC 13E3Apr 15, 2026
- PREM14AApr 15, 2026
- SCHEDULE 13G/AApr 8, 2026